SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-006087
Filing Date
2021-02-16
Accepted
2021-02-16 16:41:50
Documents
12
Period of Report
2021-02-12
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K arna-8k_20210212.htm   iXBRL 8-K 42060
  Complete submission text file 0001564590-21-006087.txt   169215

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA arna-20210212.xsd EX-101.SCH 5784
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE arna-20210212_lab.xml EX-101.LAB 18706
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arna-20210212_pre.xml EX-101.PRE 11179
5 EXTRACTED XBRL INSTANCE DOCUMENT arna-8k_20210212_htm.xml XML 3435
Mailing Address 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121
Business Address 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121 858-453-7200
ARENA PHARMACEUTICALS INC (Filer) CIK: 0001080709 (see all company filings)

IRS No.: 232908305 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-31161 | Film No.: 21639776
SIC: 2834 Pharmaceutical Preparations